ArticleClinical and translational science2024

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma.

Brendan Bender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.